Impel NeuroPharma Inc.

NASDAQ:IMPL  
10.25
+0.26 (+2.60%)
Earnings Announcements

Impel Neuropharma Announces First Quarter 2021 Financial Results And Provides Business Update

Published: 06/07/2021 13:03 GMT
Impel NeuroPharma Inc. (IMPL) - Impel Neuropharma Announces First Quarter 2021 Financial Results and Provides Business Update.
Q1 GAAP Loss per Share $15.09.
Non-GAAP Net Loss per Share Was $0.54 for Q1 of 2021.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.73

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.93

More details on our Analysts Page.